Comparative effectiveness of fenfluramine versus cannabidiol in their licensed indications for the treatment of seizures in Dravet Syndrome: a systematic review and network meta-analysis

W Linley, M Schwenkglenks, N Hawkins, T Toward
doi: https://doi.org/10.1101/2022.07.01.22277155

Data Availability

Zogenix International Ltd does not currently have a data sharing policy. All data used in the analyses are available in the cited references.

Back to top
Posted July 02, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Comparative effectiveness of fenfluramine versus cannabidiol in their licensed indications for the treatment of seizures in Dravet Syndrome: a systematic review and network meta-analysis
W Linley, M Schwenkglenks, N Hawkins, T Toward
medRxiv 2022.07.01.22277155; doi: https://doi.org/10.1101/2022.07.01.22277155
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area